Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 32

    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Farhat Nasim11 May 2019 5:43 PM IST
    New Delhi: Surrounded by controversies, Singh brothers is likely to face judicature as Fortis Healthcare Ltd (FHL) plans to a reach out to the Delhi...
    JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA

    JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA

    Meghna A Singhania10 May 2019 12:40 PM IST
    Ahmedabad: In a major relief, the notable MNC Johnson and Johnson (JnJ) has received clearance from the Gujarat Food and Drugs Control Administration...
    CDSCO officials attend biopharmaceutical industry lobbying group meeting: Objections raised

    CDSCO officials attend biopharmaceutical industry lobbying group meeting: Objections raised

    Meghna A Singhania9 May 2019 1:36 PM IST
    New Delhi: Expressing concern over the participation of senior officials of the national regulatory body Central Drugs Standard Control Organization...
    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    Meghna A Singhania8 May 2019 10:15 AM IST
    New Delhi: In order to expand its portfolio, Akum Drugs & Pharmaceuticals Ltd. presented before the Subject Experts Committee (SEC) functional...
    NPPA to revise ceiling price of Silver Sulphadiazine cream 1 pc; direct manufacturers to furnish data

    NPPA to revise ceiling price of Silver Sulphadiazine cream 1 pc; direct manufacturers to furnish data

    Meghna A Singhania7 May 2019 4:52 PM IST
    New Delhi: Through a recent Office Memorandum, National Pharmaceutical Pricing Authority (NPPA) has informed that it will soon revise the ceiling...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    Meghna A Singhania5 May 2019 12:52 PM IST
    New Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
    NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

    NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

    Meghna A Singhania4 May 2019 12:31 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Meghna A Singhania3 May 2019 1:50 PM IST
    Mumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
    JnJ hip implants: CDSCO orders compensation of over Rs 2 crore for 2 more patients

    JnJ hip implants: CDSCO orders compensation of over Rs 2 crore for 2 more patients

    Meghna A Singhania2 May 2019 11:23 AM IST
    With these two cases, the Central Drugs Standard Control Organisation (CDSCO) has so far ordered compensation to four patients, based on the...
    RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in Chennai

    RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in Chennai

    Farhat Nasim1 May 2019 12:15 PM IST
    New Delhi: In a major crackdown, the Central Drugs Standard Control Organisation (CDSCO) has confiscated bulk drugs including Erythromycin, Megestrol...
    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Meghna A Singhania30 April 2019 10:16 AM IST
    Glenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
    PrevNext

    Popular Stories

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok